Health care startups in Japan
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| BionicM | Tokyo | Series B | $4.5M | 2026-11-02 |
| Celaid Therapeutics | Tokyo | Series B | $2.5M | 2026-10-05 |
| Dioseve | Tokyo | Series A | $6.2M | 2026-06-11 |
| Restore Vision | Tokyo | Series B | $8.2M | 2026-04-15 |
| Rehab | Tokyo | Series D | $6.7M | 2024-02-16 |
| TXP Medical | Tokyo | Series C | $16.1M | 2024-10-23 |
| ThinkCyte | Hongo | Series C | $14.8M | 2024-08-29 |
| Orphe | Shibuya | Series A | $918K | 2020-01-29 |
8 rows of the CSV in 5 of its 18 columns.
- The 402 health care startups in Japan have raised $2.3B in total.
- 65 of them closed their most recent round in the last 12 months, $164.9M combined.
- The largest of those rounds is Neusignal Therapeutics' $32.8M Series B, dated June 2026.
- The most recent is Quadlytics' $3.8M Series B on 4 November 2026.
- SMBC Venture Capital is an investor in 11 of them, more than any other fund.
- Software is the most common other sector, with 117 companies (29%).
- 40% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (43% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
24 of 402| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| BionicM | BionicM develops high-performance robotic prostheses that improve mobility for people with disabilities. | Hardware | Tokyo | Series B | $4.5M | 2026-11-02 | $15.5M | UTEC - The University of Tokyo Edge Capital Partners, UTokyo Innovation Platform, Shinsei Corporate Investment +1 | 11 to 50 | 2018 |
| Celaid Therapeutics | Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. | Biotech | Tokyo | Series B | $2.5M | 2026-10-05 | $17.1M | UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners | 1 to 10 | 2020 |
| Josan-shes | Josan-shes is a web platform connecting women and families with nursing, babysitting, and childcare services. | Health care | Tokyo | Series A | $2.6M | 2026-09-15 | $3.6M | East Ventures, Partners Fund | 2021 | |
| Dioseve | Dioseve produces egg cells using DIOLs to create more reproductive possibilities. | Biotech | Tokyo | Series A | $6.2M | 2026-06-11 | $15.5M | ANRI, Coral Capital, Archetype Ventures +2 | 11 to 50 | 2021 |
| Restore Vision | Restore Vision develops a gene therapy to restore vision for patients with retinitis pigmentosa. | Biotech | Tokyo | Series B | $8.2M | 2026-04-15 | $26.7M | SMBC Venture Capital, ANRI, Spiral Capital +2 | 1 to 10 | 2016 |
| Yuimedi | Yuimedi acquires and analyzes medical data to provide accurate solutions. | Health care | Tokyo | Seed | $2.5M | 2026-02-18 | $2.6M | DG Daiwa Ventures, Google for Startups Women Founders Fund, Aozora Corporate Investment | 11 to 50 | 2020 |
| A-Wave | A-Wave manufactures and sells medical devices, pharmaceuticals, software, and hardware. | Health care | Osaka-shi | Series B | $3.5M | 2026-02-17 | $5.7M | Mitsubishi UFJ Capital, Osaka University Venture Capital, MedVenture Partners | 1 to 10 | 2023 |
| Opt Fit | Opt Fit provides fitness, wellness, and health-care services. | Health care | Nagoya | Series B | $3.2M | 2025-11-12 | $7.3M | Mizuho Capital, Deepcore, Money Forward Venture Partners +2 | 11 to 50 | 2020 |
| Airato | Airato provides radiotherapy services and develops artificial intelligence-based radiation therapy and medical devices. | Artificial intelligence | Miyagi | Seed | $1.1M | 2025-10-31 | $4.8M | GxPartners, MTG Ventures | 1 to 10 | 2022 |
| TXP Medical | TXP Medical develops medical data systems for emergency and intensive care, cancer treatment, and medical AI. | Health care | Tokyo | Series C | $16.1M | 2024-10-23 | $18.4M | UTEC - The University of Tokyo Edge Capital Partners, MPower Partners | 11 to 50 | 2017 |
| Yuurea | Yuurea develops mobile apps that analyze health metrics from urine tests and AI questionnaires. | Artificial intelligence | Nagoya | Seed | $821K | 2024-08-30 | $821K | MIRAISE, Canal Ventures, Aichi Capital +1 | 2021 | |
| ThinkCyte | ThinkCyte is a biotechnology company that sorts cells for research, diagnostics, and therapeutics. | Biotech | Hongo | Series C | $14.8M | 2024-08-29 | SMBC Venture Capital, SkyDeck Berkeley, Berkeley SkyDeck Fund | 51 to 100 | 2016 | |
| F.MED | F.MED designs and develops robotic microsurgical devices for the healthcare industry. | Hardware | Fukuoka | Series A | $2.7M | 2024-07-09 | Mitsubishi UFJ Capital, FFG Venture Business Partners, Higin Capital +1 | 1 to 10 | 2021 | |
| Ranimaru | Ranimaru provides pet sitting, pet care at events, and professional pet sitting courses. | Health care | Shibuya | Series A | $1.9M | 2024-06-10 | Resona Capital, Innovation Engine, Friendly Partners | 1 to 10 | 2020 | |
| Red Arrow Therapeutics | Red Arrow Therapeutics is a biotech firm developing systemic cytokine delivery and targeted intratumoral activation. | Biotech | Minato | Seed | $4.5M | 2024-04-23 | MassChallenge, UTEC - The University of Tokyo Edge Capital Partners, Beyond Next Ventures +2 | 11 to 50 | 2021 | |
| Ac-Planta | Ac-Planta develops, manufactures, and sells biostimulant materials for agriculture. | Biotech | Tokyo | Series A | $3.2M | 2024-03-15 | Global Brain Corporation, SMBC Venture Capital, SVG Ventures +1 | 1 to 10 | 2018 | |
| Rehab | Rehab provides information and communication technology and digital services for the medical care field. | Health care | Tokyo | Series D | $6.7M | 2024-02-16 | $24.4M | Global Brain Corporation, Mitsubishi UFJ Capital, SMBC Venture Capital +2 | 101 to 250 | 2016 |
| MELON | MELON creates scientifically based mindfulness programs and delivers them in a specialized studio. | Education | Minato | Seed | $815K | 2024-01-16 | Toranomon Impact Capital | 1 to 10 | 2019 | |
| mediVR | mediVR makes medical equipment that applies virtual reality video technology. | Artificial intelligence | Osaka | Series B | $4.6M | 2021-07-08 | $7.2M | Osaka University Venture Capital | 1 to 10 | 2016 |
| Atonarp | Atonarp analyzes chemical composition by combining molecular science with data processing algorithms. | Energy | Tokyo | Series D | $50.0M | 2021-05-18 | $101.5M | SMBC Venture Capital, SBI Investment, Venture Labo Investment +1 | 51 to 100 | 2009 |
| Genoplan | Genoplan provides DNA testing and genetic analysis services. | Artificial intelligence | Fukuoka | Series C | $9.2M | 2020-12-28 | SBVA, SparkLabs Accelerator, Samsung Ventures +1 | 11 to 50 | 2014 | |
| HACARUS | Hacarus is a medical technology company that uses AI to develop check series and workplace safety tools. | Artificial intelligence | Kyoto | Series B | $12.4M | 2020-11-16 | $24.3M | Miraidoa, Resona Capital, Miyako Capital +1 | 51 to 100 | 2014 |
| Orphe | Orphe builds smart footwear and sensing platforms that capture motion and pressure data. | Hardware | Shibuya | Series A | $918K | 2020-01-29 | $3.4M | Mistletoe, Monozukuri Ventures, ASICS Ventures Corporation +1 | 11 to 50 | 2014 |
| BCC | BCC is a consulting company offering IT sales outsourcing, human resource development, and healthcare recreation support. | Health care | Osaka | Seed | $929K | 2016-07-11 | Mizuho Capital, Sansei Capital Investment, K&P Partners | 101 to 250 | 2002 |
Table 1. Health care startups in Japan: the 24 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 402.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Restore Vision | Restore Vision develops a gene therapy to restore vision for patients with retinitis pigmentosa. | Biotech | Tokyo | Series B | $8.2M | 2026-04-15 | $26.7M | SMBC Venture Capital, ANRI, Spiral Capital +2 | 1 to 10 | 2016 |
| 2 | Dioseve | Dioseve produces egg cells using DIOLs to create more reproductive possibilities. | Biotech | Tokyo | Series A | $6.2M | 2026-06-11 | $15.5M | ANRI, Coral Capital, Archetype Ventures +2 | 11 to 50 | 2021 |
| 3 | BionicM | BionicM develops high-performance robotic prostheses that improve mobility for people with disabilities. | Hardware | Tokyo | Series B | $4.5M | 2026-11-02 | $15.5M | UTEC - The University of Tokyo Edge Capital Partners, UTokyo Innovation Platform, Shinsei Corporate Investment +1 | 11 to 50 | 2018 |
| 4 | A-Wave | A-Wave manufactures and sells medical devices, pharmaceuticals, software, and hardware. | Health care | Osaka-shi | Series B | $3.5M | 2026-02-17 | $5.7M | Mitsubishi UFJ Capital, Osaka University Venture Capital, MedVenture Partners | 1 to 10 | 2023 |
| 5 | Josan-shes | Josan-shes is a web platform connecting women and families with nursing, babysitting, and childcare services. | Health care | Tokyo | Series A | $2.6M | 2026-09-15 | $3.6M | East Ventures, Partners Fund | 2021 | |
| 6 | Celaid Therapeutics | Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. | Biotech | Tokyo | Series B | $2.5M | 2026-10-05 | $17.1M | UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners | 1 to 10 | 2020 |
| 7 | Yuimedi | Yuimedi acquires and analyzes medical data to provide accurate solutions. | Health care | Tokyo | Seed | $2.5M | 2026-02-18 | $2.6M | DG Daiwa Ventures, Google for Startups Women Founders Fund, Aozora Corporate Investment | 11 to 50 | 2020 |
Table 2. Health care startups in Japan: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | SMBC Venture Capital | Corporate venture arm | Tokyo, Japan | 11 | 3% | 1 | Restore Vision |
| 2 | ANRI | Venture capital firm | Tokyo, Japan | 10 | 2% | 3 | Dioseve, Restore Vision, Cosomil |
| 3 | UTEC - The University of Tokyo Edge Capital Partners | Venture capital firm | Tokyo, Japan | 7 | 2% | 2 | BionicM, Celaid Therapeutics |
| 4 | Nissay Capital | Venture capital firm | Tokyo, Japan | 7 | 2% | ||
| 5 | Global Brain Corporation | Venture capital firm | Tokyo, Japan | 6 | 1% | ||
| 6 | Mitsubishi UFJ Capital | Corporate venture arm | Tokyo, Japan | 6 | 1% | 1 | A-Wave |
| 7 | Mizuho Capital | Venture capital firm | Tokyo, Japan | 5 | 1% | ||
| 8 | Osaka University Venture Capital | Venture capital firm | Osaka, Japan | 4 | 1% | 2 | Celaid Therapeutics, A-Wave |
| 9 | Lifetime Ventures | Startup incubator | Yokohama, Japan | 4 | 1% | ||
| 10 | MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC) | Venture capital firm | Tokyo, Japan | 4 | 1% | ||
| 11 | SBI Investment | Venture capital firm | Minato, Japan | 4 | 1% | ||
| 12 | Nippon Venture Capital | Corporate venture arm | Tokyo, Japan | 4 | 1% | ||
| 13 | Spiral Capital | Venture capital firm | Tokyo, Japan | 3 | 1% | 2 | Dioseve, Restore Vision |
| 14 | Sony Innovation Fund | Corporate venture arm | Tokyo, Japan | 3 | 1% | ||
| 15 | Beyond Next Ventures | Startup accelerator | Tokyo, Japan | 3 | 1% |
Table 3. Health care startups in Japan: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 117 | 29% | $416.7M |
| Biotech | 106 | 26% | $800.1M |
| Artificial intelligence | 50 | 12% | $229.7M |
| Hardware | 27 | 7% | $126.6M |
| Commerce | 14 | 3% | $5.6M |
| Fintech | 10 | 2% | $5.3M |
| Education | 7 | 2% | $20.2M |
| Energy | 4 | 1% | $105.0M |
| Cybersecurity | 1 | 0% |
Table 4. Health care startups in Japan by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Japan by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Tokyo | 201 | 50% |
| Osaka | 16 | 4% |
| Kyoto | 13 | 3% |
| Minato | 9 | 2% |
| Shibuya | 8 | 2% |
| Fukuoka | 8 | 2% |
| Hongo | 7 | 2% |
| Nagoya | 6 | 1% |
| Tsukuba | 6 | 1% |
| Kobe | 6 | 1% |
| Osaka-shi | 5 | 1% |
| Fujisawa | 5 | 1% |
Table 6. Health care startups in Japan by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 3 | 5% | $9.0M |
| October 2026 | 4 | 6% | $7.1M |
| September 2026 | 5 | 8% | $12.9M |
| August 2026 | 5 | 8% | $2.0M |
| July 2026 | 3 | 5% | $4.6M |
| June 2026 | 6 | 9% | $48.1M |
| May 2026 | 5 | 8% | $37.6M |
| April 2026 | 11 | 17% | $21.6M |
| March 2026 | 5 | 8% | $5.9M |
| February 2026 | 7 | 11% | $6.2M |
| January 2026 | 7 | 11% | $6.2M |
| December 2025 | 2 | 3% | |
| November 2025 | 2 | 3% | $3.6M |
Table 7. Health care startups in Japan: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 61 | 15% | $161.3M |
| 2025 | 67 | 17% | $365.5M |
| 2024 | 61 | 15% | $252.6M |
| 2023 | 29 | 7% | $110.0M |
| 2022 | 25 | 6% | $242.4M |
| 2021 | 41 | 10% | $298.9M |
Table 8. Health care startups in Japan by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 55 | 14% |
| 2020 to 2022 | 104 | 26% |
| 2015 to 2019 | 176 | 44% |
| 2010 to 2014 | 34 | 9% |
| Before 2010 | 29 | 7% |
Table 9. Health care startups in Japan by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 136 | 41% |
| 11 to 50 | 145 | 43% |
| 51 to 100 | 31 | 9% |
| 101 to 250 | 16 | 5% |
| 251 to 500 | 2 | 1% |
| 501 to 1,000 | 2 | 1% |
| 1,001 to 5,000 | 2 | 1% |
| 10,001 or more | 1 | 0% |
Table 10. Health care startups in Japan by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Japan. On 16 November 2026 that is 402 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 24 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 402 rows: 121 have no round amount, 0 no city and 126 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Japan are on the list?
- 402, in the file dated 16 November 2026. 65 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 402 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.